High-rolling investors have positioned themselves bearish on Marvell Tech MRVL, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.

Whales with a lot of money to spend have taken a noticeably bearish stance on Goldman Sachs Gr. Looking at options history for Goldman Sachs Gr GS we detected 23 trades. If we consider the specifics of each trade, it is accurate to state that 17% of the investors opened trades with bullish ...

AXIL will launch a Monster Jam-branded hearing protection line, including earbuds, earmuffs, and hearing devices, in 2025. The partnership highlights AXIL's commitment to hearing safety while capturing the excitement of Monster Jam's high-energy events.

On the Auction Date, between 10:30 a.m. and 11:00 a.m., the Government Debt Management will auction Treasury bonds in the Series, with the ISIN number and with the Maturity Date according to the table above. Article 6 of the General Terms of Auction for Treasury bonds applies for the right to ...

Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Innovative Industrial Properties To Contact Him Directly To Discuss Their Options

Press ReleaseVELIZY-VILLACOUBLAY, France - February ...

Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Crocs To Contact Him Directly To Discuss Their Options

U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Wednesday. The Dow traded down 0.33% to 44,408.16 while the NASDAQ fell 0.40% to 19,961.29. The S&P 500 also fell, dropping, 0.21% to 6,116.69. Energy shares jumped by 1.6% on Wednesday.

Users can now access fee-free USD deposits and withdrawals through bank transfers and trade over 160 cryptocurrencies on Binance.US. Binance.US's COO cites regulatory pressures after FTX collapse as hampering business, forcing staff reductions, and restricting fiat access.

NEW HAVEN, Conn., Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- OrphAI Therapeutics Inc. ( "OrphAI" ) , a clinical-stage biopharmaceutical company developing novel therapeutics for diseases with unmet needs, announced today the appointment of Aaron B. Waxman, M.D., Ph.D. to its Board of Directors.